window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 29, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital & Data

  • Digital & Data,Drug Discovery & Development

    Promise Bio launches grant to support translational epiproteomics in biotech research

    Promise Bio has launched the Frontier Epiproteomic Innovation Grant, providing [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Evinova secures collaborations with Astellas, AstraZeneca and Bristol Myers Squibb to share clinical trial data for AI benchmarking

    Evinova has announced collaborations with Astellas Pharma, AstraZeneca and Bristol [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Evogene partners QUT on AI drug discovery for lung cancer resistance

    Evogene Ltd has partnered with Queensland University of Technology to [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Within3 launches Dataverse to integrate real-world data into pharma launch intelligence platform

    Within3 has launched Dataverse, a partner ecosystem designed to extend [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    AI and medical affairs strategy set to redefine life sciences in 2026

    Artificial intelligence, shifting healthcare professional behaviour and rising pressure on [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Nuclera and leadXpro partner on AI-guided workflow for membrane protein drug discovery

    Nuclera and leadXpro have entered a scientific partnership to develop [...]

    May 5, 2026
  • Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Insilico Medicine and CMS announce AI-powered drug discovery collaborations in CNS and autoimmune diseases

    Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing

    New England Biolabs launches Monarch Mag Cell-free DNA extraction kit for scalable cfDNA isolation

    New England Biolabs has launched the Monarch Mag Cell-free DNA [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Transitioning to risk-based clinical trial management under ICH E6(R3)

    Risk-based quality management (RBQM) is becoming central to clinical trial [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close

    IgniteData has appointed Laura Hilty as chief strategy officer and [...]

    May 5, 2026
Previous567Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Atsena advances gene therapy ATSN-201 into Phase 3 trial for inherited blindness
    Categories: Advanced Therapies, Clinical & Regulatory, Genomics and sequencing, Therapeutic Areas
  • Pierre Fabre wins EU approval for first-line BRAFTOVI regimen in BRAF-mutant colorectal cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • African health leaders launch Imara framework to strengthen sickle cell disease care across Africa
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top